C

Cigna Group
XMUN:CGN

Watchlist Manager
Cigna Group
XMUN:CGN
Watchlist
Price: 226.85 EUR -0.48%
Market Cap: €66.4B

Cigna Group
Stock-Based Compensation

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Cigna Group
Stock-Based Compensation Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Stock-Based Compensation CAGR 3Y CAGR 5Y CAGR 10Y
C
Cigna Group
XMUN:CGN
Stock-Based Compensation
$291m
CAGR 3-Years
3%
CAGR 5-Years
0%
CAGR 10-Years
10%
Quest Diagnostics Inc
NYSE:DGX
Stock-Based Compensation
$88m
CAGR 3-Years
5%
CAGR 5-Years
-2%
CAGR 10-Years
5%
CVS Health Corp
NYSE:CVS
Stock-Based Compensation
$535m
CAGR 3-Years
6%
CAGR 5-Years
6%
CAGR 10-Years
9%
Cigna Corp
NYSE:CI
Stock-Based Compensation
$291m
CAGR 3-Years
3%
CAGR 5-Years
0%
CAGR 10-Years
10%
Laboratory Corporation of America Holdings
NYSE:LH
Stock-Based Compensation
$125.8m
CAGR 3-Years
3%
CAGR 5-Years
2%
CAGR 10-Years
2%
Guardant Health Inc
NASDAQ:GH
Stock-Based Compensation
$166.2m
CAGR 3-Years
21%
CAGR 5-Years
3%
CAGR 10-Years
N/A
No Stocks Found

Cigna Group
Glance View

Cigna Group, a recognized titan in the health services landscape, traces its origins to 1792 when it began as the Insurance Company of North America (INA). This rich history speaks volumes about its deep-rooted expertise and robust resilience in an ever-evolving industry. Today, Cigna operates as a global health services powerhouse, deriving its core revenues from an intricate blend of health insurance products and services targeted towards employers, individuals, and government entities. The company's ability to seamlessly fuse traditional insurance models with innovative health solutions highlights its commitment to improving patient outcomes. Cigna's operational model is anchored on its extensive provider network, supplemented by a suite of digital health tools aimed at enhancing customer engagement. This hybrid approach not only simplifies access to medical care but also reinforces its strategic focus on affordability and personalized health journeys for its clients. Financially, Cigna's success is a byproduct of its diversified revenue streams, encompassing global health care, international markets, and supplemental health benefits. At its core, Cigna makes money through premium collections, investment income, and administrative fees from managing prescription drug plans and health services. With the acquisition of Express Scripts in 2018, Cigna prominently positioned itself in the pharmacy benefits management sector, adding another lucrative revenue channel. This strategic maneuver has fostered vertical integration within the company, aligning its pharmacy services with its insurance offerings to manage costs more effectively. Through a relentless pursuit of operational efficiency and strategic expansion, Cigna continues to leverage its scale and diversified offerings, remaining a key player in delivering accessible and cost-effective health care solutions worldwide.

CGN Intrinsic Value
509.12 EUR
Undervaluation 55%
Intrinsic Value
Price
C

See Also

What is Cigna Group's Stock-Based Compensation?
Stock-Based Compensation
291m USD

Based on the financial report for Dec 31, 2025, Cigna Group's Stock-Based Compensation amounts to 291m USD.

What is Cigna Group's Stock-Based Compensation growth rate?
Stock-Based Compensation CAGR 10Y
10%

Over the last year, the Stock-Based Compensation growth was -6%. The average annual Stock-Based Compensation growth rates for Cigna Group have been 3% over the past three years , and 10% over the past ten years .

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett